Drug Type Fusion protein |
Synonyms- |
Target |
Mechanism PBGD stimulants(Porphobilinogen deaminase stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Porphyrias | Preclinical | US | 12 Jan 2022 | |
Porphyrias | Preclinical | ES | 12 Jan 2022 | |
Porphyrias | Preclinical | US | 12 Jan 2022 |